JP Patent

JP3420549B2 — 抗癌性化合物を製造するための方法と中間体

Assigned to ファイザー・プロダクツ・インク · Expires 2003-06-23 · 23y expired

What this patent protects

Patent listed against lenvatinib-mesylate.

Drugs covered by this patent

lenvatinib-mesylate (LENVATINIB MESYLATE)

Patent Metadata

Patent number: JP3420549B2
Jurisdiction: JP
Classification: —
Expires: 2003-06-23
Drug substance claim: No
Drug product claim: No
Assignee: ファイザー・プロダクツ・インク
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.